+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genmab AS - logo

Genmab is a leading biotechnology company that focuses on developing innovative antibody products. Arzerra is the company’s first marketed antibody and is approved to treat chronic lymphocytic leukemia (CLL) patients in all major markets. Another product, Darzalex, has been approved in the United States for the treatment of patients with multiple myeloma. Genmab was founded in Copenhagen, Denmark in 1999 and employs around 200 people.

From
Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2020 - Product Thumbnail Image

Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 419 Pages
From
From
From
From
From
mRNA Therapeutics and Vaccines Market, 2020-2030 - Product Thumbnail Image

mRNA Therapeutics and Vaccines Market, 2020-2030

  • Report
  • January 2021
  • 253 Pages
From
From
From
From
From
From
From
From
Loading Indicator